• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种治疗门体性脑病的新疗法。

A new therapy for portal systemic encephalopathy.

作者信息

Mendenhall C L, Rouster S, Marshall L, Weesner R

出版信息

Am J Gastroenterol. 1986 Jul;81(7):540-3.

PMID:3717115
Abstract

This report describes a new therapeutic approach to the treatment of adults with portal systemic encephalopathy using sodium benzoate and sodium phenylacetate, two compounds that increase conjugated nitrogen excretion in the urine and that have been shown to be an effective treatment for children with congenital hyperammonemia. The study was a double-blind cross-over study in which each patient was his own control. All patients either improved their mental status (six of eight) or maintained a mental status comparable to that achieved with conventional therapy [lactulose or neomycin (two of eight)]. All decreased their blood ammonias on these medications and seven of eight improved their portal systemic encephalopathy index. It is suggested that these medications may be useful in the treatment of portal systemic encephalopathy.

摘要

本报告描述了一种治疗成人门体性脑病的新方法,即使用苯甲酸钠和苯乙酸钠,这两种化合物可增加尿中结合氮的排泄,且已被证明对先天性高氨血症儿童有效。该研究为双盲交叉研究,每位患者自身作为对照。所有患者要么改善了精神状态(8例中的6例),要么维持了与传统疗法(乳果糖或新霉素,8例中的2例)相当的精神状态。所有患者在使用这些药物后血氨水平均下降,8例中的7例改善了门体性脑病指数。提示这些药物可能对门体性脑病的治疗有用。

相似文献

1
A new therapy for portal systemic encephalopathy.一种治疗门体性脑病的新疗法。
Am J Gastroenterol. 1986 Jul;81(7):540-3.
2
Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial.苯甲酸钠治疗急性肝性脑病:一项双盲随机试验。
Hepatology. 1992 Jul;16(1):138-44. doi: 10.1002/hep.1840160123.
3
Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.化疗后高氨血症性脑病。苯甲酸钠和苯乙酸钠治疗后的生存情况。
J Clin Gastroenterol. 1997 Dec;25(4):682-4. doi: 10.1097/00004836-199712000-00026.
4
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.乳果糖与新霉素治疗慢性门体性脑病的比较。一项双盲对照试验。
Gastroenterology. 1977 Apr;72(4 Pt 1):573-83.
5
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.L-鸟氨酸-L-天冬氨酸输注对肝硬化和肝性脑病患者的治疗效果:一项安慰剂对照双盲研究的结果
Hepatology. 1997 Jun;25(6):1351-60. doi: 10.1002/hep.510250609.
6
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.利福昔明与新霉素治疗肝硬化患者慢性门体性脑病高氨血症的疗效比较:一项双盲随机试验
Ital J Gastroenterol. 1991 May;23(4):175-8.
7
Long-term treatment of girls with ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症女孩的长期治疗。
N Engl J Med. 1996 Sep 19;335(12):855-9. doi: 10.1056/NEJM199609193351204.
8
[Sodium benzoate in portal-systemic-encephalopathy-induced blood ammonia normalization and clinical improvement. Interim report of a double-blind multicenter trial].[苯甲酸钠在门体性脑病所致血氨正常化及临床改善中的作用。一项双盲多中心试验的中期报告]
Rev Invest Clin. 1990 Jul;42 Suppl:149-54.
9
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.新霉素-山梨醇和乳果糖治疗急性门体性脑病:一项对照双盲临床试验
Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.
10
Sodium benzoate and lactulose for the treatment of hepatic encephalopathy.苯甲酸钠和乳果糖用于治疗肝性脑病。
J Hepatol. 1994 Dec;21(6):1144. doi: 10.1016/s0168-8278(05)80633-6.

引用本文的文献

1
Sodium benzoate for the treatment of hepatic encephalopathy in humans and animals: a systematic review and meta-analysis.苯甲酸钠用于治疗人和动物肝性脑病:一项系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2025 Apr 1;37(4):488-496. doi: 10.1097/MEG.0000000000002911. Epub 2024 Dec 19.
2
Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.专门针对氨用于预防和治疗肝硬化成年患者肝性脑病的药物疗法。
Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD012334. doi: 10.1002/14651858.CD012334.pub2.
3
Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.
甘氨酸与高氨血症:肝性脑病治疗的潜在靶点。
Metab Brain Dis. 2016 Dec;31(6):1269-1273. doi: 10.1007/s11011-016-9858-2. Epub 2016 Jun 23.
4
Sodium benzoate for treatment of hepatic encephalopathy.苯甲酸钠用于治疗肝性脑病。
Gastroenterol Hepatol (N Y). 2013 Apr;9(4):219-27.
5
Current trends in the treatment of hepatic encephalopathy.当前肝性脑病治疗的趋势。
Ther Clin Risk Manag. 2009 Jun;5(3):617-26. doi: 10.2147/tcrm.s4443. Epub 2009 Aug 3.
6
Hepatic encephalopathy: a review of its pathophysiology and treatment.肝性脑病:其病理生理学与治疗的综述
Curr Treat Options Gastroenterol. 2006;9(6):464-74. doi: 10.1007/s11938-006-0003-x.
7
[Hepatic encephalopathy].[肝性脑病]
Nervenarzt. 2003 Dec;74(12):1078-87. doi: 10.1007/s00115-003-1579-1.
8
Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.肝硬化中的肝性脑病:发病机制、诊断与管理
Drugs. 2000 Dec;60(6):1353-70. doi: 10.2165/00003495-200060060-00008.
9
Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.三例在急性高氨血症治疗过程中发生的静脉注射苯甲酸钠和苯乙酸钠中毒病例。
J Inherit Metab Dis. 2000 Mar;23(2):129-36. doi: 10.1023/a:1005661631281.
10
Synergistic inhibition of human rhabdomyosarcoma cells by sodium phenylacetate and Tretinoin.
In Vitro Cell Dev Biol. 1993 Mar;29A(3 Pt 1):189-91. doi: 10.1007/BF02634180.